Helstu atriði úr fjárhagsuppgjöri 3F 2025Vörusala var 111 m€ á fjórðungnum samanborið við 110 m€ á þriðja fjórðungi 2024 Hagnaður var 29 m€ á fjórðungnum samanborið við 19 m€ á þriðja fjórðungi 2024 EBITDA var 42 m€ og EBITDA hlutfall 37,3% Eignir hafa lækkað um 13 m€ frá áramótum og voru 983 m€ í lok tímabilsins Eigið fé þann 30. september 2025 var 505 m€ og eignfjárhlutfall 51,4%Guðmundur Kristjánsson, forstjóri: „Afkoma þriðja fjórðungs er góð og eru það tveir þættir sem skipta mestu máli. Veiðar og vinnsla á makríl gengu vel og verð á sjávarafurðum er hátt um þessar mundir. Þegar við horfum til seinustu 12 mánaða er ávöxtun eigin fjár 12%. Í september var tilkynnt um kauptilboð félagsins í allt hlutafé Lýsis hf. Með kaupunum sér Brim mikil samlegðar- og sóknarfæri bæði tengt hráefnaöflun Lýsis og fyrir Brim til að ná lengra í...

AUSTIN, Texas, Nov. 20, 2025 (GLOBE NEWSWIRE) — Golden Triangle Ventures, Inc. released its Quarterly Report for the period ending September 30, 2025, reflecting a pivotal quarter defined by meaningful revenue growth, improved profitability, strengthened shareholder equity, and the early results of the Company’s comprehensive restructuring under new leadership. Q3 2025 marks a clear turning point in the Company’s trajectory — a shift from legacy challenges to a clean, growth-ready platform supported by strong operational performance. Q3 2025 Financial Performance According to the Company’s official Q3 Quarterly Report, Golden Triangle Ventures generated:Total Revenue: $2,051,088 Construction Revenue: $1,511,140 Gross Profit: $1,711,097 Net Income: $1,007,767, compared to a $(388,921) loss in Q3 2024 Year-to-date Net Income: $1,020,055,...

Company Successfully Advances Several New Branding and Marketing Initiatives Strengthens Balance Sheet; Converts $27 Million of Corporate Liabilities into Equity New HealthMD Subsidiary to Deliver New Holistic Products, Integrate AI TechLOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) — Limitless X Holdings Inc. (OTCQX: LIMX), a global health, wellness, and lifestyle company founded by entrepreneur Jas Mathur, today announced operational and financial highlights of its third quarter of 2025 ended September 30, 2025. Results reflect several new marketing initiatives, including a pivot to bring most sales and marketing activities in-house, which is expected to increase ROI and raise profit margins, as well as a restructuring to strengthen the Company’s financial position. Q3 2025 and Recent Operating HighlightsFormed HealthMD Inc.,...

In the nine months of 2025, the net turnover was 1 444.4 thousand. EUR, which is 21.0% more than in the nine months of the previous year, but the profit before taxes was 95.5 thousand. EUR – by 11.1 thousand EUR more compared to the corresponding period of the previous year. JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’ (hereinafter referred to as the Company) is the only producer of high-quality breeding bull semen and one of the largest suppliers of it in Latvia. The second largest field of the Company’s basic economic activities is the milk testing services. The Company also provides other breeding related services – consultations on issues of cattle breeding, feeding and keeping, evaluation of cow exterior, artificial insemination of cows, initial processing of the supervisory data. The company offers Latvian farms the...

ATHENS, Greece, Nov. 20, 2025 (GLOBE NEWSWIRE) — Dynagas LNG Partners LP (NYSE: “DLNG”) (the “Partnership”), an owner and operator of liquefied natural gas (“LNG”) carriers, today announced its results for the three and nine months ended September 30, 2025. Nine months Highlights:Net Income and Earnings per common unit (basic and diluted) of $45.9 million and $0.99, respectively; Adjusted Net Income(1) of $43.0 million and Adjusted Earnings per common unit(1) (basic and diluted) of $0.91; Adjusted EBITDA(1) of $82.4 million; and 99.5% fleet utilization(2).Quarter Highlights:Net Income and Earnings per common unit (basic and diluted) of $18.7 million and $0.48, respectively; Adjusted Net Income(1) of $14.2 million and Adjusted Earnings per common unit(1) (basic and diluted) of $0.36; Adjusted EBITDA(1) of $27.6 million; 99.1%...

ATHENS, Greece, Nov. 20, 2025 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today reported net income of $7.2 million and net income attributable to common stockholders of $5.7 million for the third quarter of 2025. This compares to a net income of $3.7 million and a net income attributable to common stockholders of $2.3 million for the third quarter of 2024. Earnings per share for the third quarter of 2025 were $0.05 basic and diluted, compared to $0.02 basic and $0.00 diluted in the same quarter of 2024. Time charter revenues were $51.9 million for the third quarter of 2025, compared to $57.5 million for the same quarter of 2024. The decrease in time charter revenues, compared to the same quarter last year,...

$4 billion in Minimum Contracted Revenue Gross Revenues of $577 million and net income of $103 million, or $2.75 per share $1.00 New Common Share Dividend, following $0.60 July 2025 Semi- Annual Payment Dynamic growth – 20 Vessel Total Newbuilding Program Including Three VLCCs Stronger Tanker Fundamentals Supported by Market Tightness and Geopolitics ATHENS, Greece, Nov. 20, 2025 (GLOBE NEWSWIRE) — TEN, Ltd (TEN) (NYSE: TEN) (the “Company”) today reported results (unaudited) for the nine months and third quarter ended September 30, 2025. NINE MONTHS 2025 SUMMARY RESULTSTEN’s fleet generated $577 million in gross revenues resulting in approx. $171 million in operating income inclusive of $12.5 million in capital gains from the sale of four older vessels. The net income for the first nine months of 2025 was $103 million or $2.75...

ROGERS, Ark., Nov. 20, 2025 (GLOBE NEWSWIRE) — America’s Car-Mart, Inc. (NASDAQ: CRMT) today announced it will release fiscal 2026 second quarter financial results on Thursday, December 4, 2025, before the market opens. A webcast and conference call will be held that same day at 9:00 a.m. ET to review the Company’s results. Participants may access the conference call via webcast using this link: Webcast Link Here. To participate via telephone, please register in advance using this Registration Link. Upon registration, all telephone participants will receive a one-time confirmation email detailing how to join the conference call, including the dial-in number along with a unique PIN that can be used to access the call. All participants are encouraged to dial-in 10 minutes prior to the start time. A replay of the conference call and...

 —Nebokitug PSC Phase 3 Design Near Completion Following Positive FDA Feedback— —Regulatory Alignment Advances, with EMA Guidance Supporting a Single Nebokitug Phase 3 Registration Trial Using a Clinical Event Composite Endpoint— —Phase 2 SPRING Trial OLE Data Showing Favorable Safety and Consistent Improvements in Key Biomarkers in PSC Patients Treated with Nebokitug for Up to 48 Weeks Presented at AASLD 2025— —New Clinical Data Presented at AASLD 2025 Provides Insights on Nebokitug’s Direct Macrophage-Mediated Mechanisms that Are Relevant to Halting or Slowing PSC Disease Progression— —Multiple Partnering Options for Supporting the Nebokitug Phase 3 Program Continue to Advance— —Cash Runway Expected through End of Fourth Quarter of 2026— TEL AVIV, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) — Chemomab Therapeutics Ltd. (Nasdaq: CMMB),...

Management to host conference call and webcast Thursday, November 20, 2025, at 8:30 AM ET Company advances commercialization and is on track to meet year-end system deployment target PETAH TIKVA, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the third quarter ended September 30, 2025, and provided a business update. Recent Highlights:Generated $3.4 million in revenue in the third quarter of 2025, compared to $3.0 million in the third quarter of 2024. Acquired 100% of the stock of Vaso Healthcare IT, a provider of healthcare information technologies solutions, for cash and future operational based earnouts. Secured new commercial collaborations to accelerate commercialization of the Nanox.ARC and...